Starpharma presents at ASX Investor Series

Feb 17th, 2015

Starpharma is presenting to more than 200 investors at ASX Investor Series event in Sydney.

 The ASX Investor Series is hosted by the ASX in conjunction with Finance News Network (FNN) and is designed to engage the investment community and bring together ASX-listed companies, investors and financial market participants.

Watch Interview Video

Read More

Interim Report and Half-Year Financial Results

Feb 16th, 2015

Starpharma today released its interim report and financial results for the half-year ended 31 December 2014.


Financial Summary

  • Reported loss of $8.5M (Dec 2013: $5.6M)
  • Cash position at 31 December 2014 of $39.3M
  • R&D tax incentives of $1.6M reported in the half-year (Dec 2013: $2.6M)
  • Receipt of $4.2M R&D tax incentive refund
  • $20.5M net proceeds from equity placement and share purchase plan
Read More

Quarterly Cashflow Report

Jan 28th, 2015

Starpharma today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 December 2014.

Read More

Starpharma to present at Biotech Showcase

Jan 12th, 2015

Starpharma today announced that CEO Dr Jackie Fairley will present at the 7th Annual Biotech ShowcaseTM conference in San Francisco this week. The Biotech ShowcaseTM coincides with the Annual J.P. Morgan Healthcare Conference, which Starpharma is also attending.

Read More